Bharat Biotech’s intra-nasal COVID vaccine gets DCGI nod for phase-II and -III trials
Phase-I clinical trial has been completed in age groups ranging from 18 to 60 years
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.